Lab Director |
|||
 |
Dean Felsher, MD, PhD | ||
Staff |
|||
 |
Lowen Lee |
 |
Qiwei Yang Transgenics manager - The most senior member of the Felsher lab, Qiwei Yang is responsible for maintaining the transgenic animals. |
 |
Liwen Xu, PhD Research Associate - Investigate the involvement of Wnt signaling pathway in lymphomagenesis, regression and relapse of lymphomas. |
||
Jessica Dermody, Ph.D. Yen Feng Leslie Quiroz |
|||
Instructors (Specific Area of Research ) |
|||
 |
Alice Fan, MD Dr. Fan is a lymphoma oncologist focusing on inactivation of oncogenes in preclinical and clinical studies. Using conditional mouse models, she studies how oncogenes cooperate in the initiation and maintenance of lymphoma. She also uses these preclinical mouse models to validate new nanotechnology strategies for the diagnosis and treatment of lymphoma. She has opened a clinical trial studying atorvastatin for the treatment of patients with certain non-hodgkin's lymphomas.
|
||
Post-Doctoral Fellows |
|||
 |
Stacey Adam, PhD Investigation into MYC-induced osteosarcoma tumor formation, regression, and relapse. |
 |
Yulin Li, PhD Investigating the mechanism of cell death upon MYC inactivation in murine lymphoma. |
 |
David Bellovin, PhD Characterization of MYC-induced hepatocellular carcinoma and identification of liver cancer stem cells. |
 |
Jan van Riggelen, PhD Understanding the epigenetic influence on MYC-induced tumor formation, regression, and relapse. |
 |
Zhongwei Cao, PhD Elucidating the mechanism of statin-mediated MYC-induced tumor regression. |
 |
Phuoc Tran, MD, PhD Contributing effects of multiple oncogenes on lung tumor formation and regression. |
 |
George Horng, MD Deveopment of tools for in vivo imaging of lung tumor development. |
 |
Aleksey Yevtodiyenko, PhD Conditional inhibition of MYC expression in human and murine lymphoma. |
Graduate Students |
|||
 |
Pavan Bachireddy |
 |
Kavya Rakhra Studying the role of the immune system in tumor regression and relapse. |
 |
Peter Choi Perhaps the role of MYC in T-Cell development and lymphoma formation??? |
 |
Alper Yetil Characterizing senescence signaling in MYC-induced lymphoma regression and relapse. |
 |
Mathias Orban Molecular characterization of patient response in a clinical trial of Statin treatment |
||
Undergraduate Students |
|||
Sashendra Aponso Development of RNA interference to investigate the role of MYC in murine tumorigenesis. |
 |
Evan Chen Studying the mechanism of liver cancer cell differentiation upon MYC inactivation |
|
 |
Ramya Parameswaran Investigating the role of Bim1 in MYC-induced lymphomagenesis. |
Michael Sanchez Investigating novel domains of MYC for their ability to maintain osteosarcoma. | |
Former Lab Members |
|||